13.02
price up icon0.15%   0.02
after-market After Hours: 13.02
loading

Bicara Therapeutics Inc Stock (BCAX) Forecast

The Bicara Therapeutics Inc (BCAX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.00, representing a -100.00% decrease from the current price of $13.02. The highest analyst price target is $0.00, and the lowest is $0.00.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BCAX Price Target
Average 0.00 (-100.00% Downside)
loading

Is Bicara Therapeutics Inc (BCAX) A Buy Now?

Oscillators
Name Value Action
RSI(14) 45.41 Neutral
STOCH(9,6) 53.46 Neutral
STOCHRSI(14) 100.00 Sell
MACD(12,26) -0.8214 Buy
ADX(14) 23.76 Neutral
William %R -31.67 Neutral
CCI(14) 24.74 Neutral
Buy: 1 Sell: 1 Neutral: 5
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
12.53
Buy
12.61
Buy
MA20
12.31
Buy
13.02
Sell
MA50
15.74
Sell
15.33
Sell
MA100
19.16
Sell
19.17
Sell
MA200
9.8416
Buy
0.00
Buy
Buy: 5 Sell: 5 Neutral: 0
Summary: Neutral
According to our latest analysis, BCAX could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 6 signaling Sell signals and 5 Neutral signals. This suggests that investors should exercise caution when entering new positions on BCAX, as the market is likely to remain volatile in the near term.
  1. RSI (Relative Strength Index): The RSI(14) value of 45.41 indicates that BCAX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 53.46 indicates that BCAX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that BCAX is oversold. This suggests that BCAX price is at or near the highest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 23.76 suggests that there may be some movement in price, but it lacks strength or conviction.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 24.74 indicates that BCAX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Bicara Therapeutics Inc Stock (BCAX) Year by Year Forecast

$79.89
price up icon 2.27%
$32.25
price up icon 1.67%
$4.47
price down icon 5.10%
$353.31
price up icon 2.22%
biotechnology ONC
$221.22
price up icon 0.71%
$114.50
price down icon 0.67%
Cap:     |  Volume (24h):